Angiodynamics Inc (ANGO)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
James C. Clemmer
Employees:
760
14 PLAZA DRIVE, LATHAM, NY 12110
5187981215

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems.

Data derived from most recent annual or quarterly report
Market Cap 368.252 Million Shares Outstanding39.134 Million Avg 30-day Volume 248.321 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.78
Price to Revenue1.4615 Debt to Equity0.1501 EBITDA-6.324 Million
Price to Book Value1.23 Operating Margin-10.9781 Enterprise Value518.694 Million
Current Ratio2.191 EPS Growth0.087 Quick Ratio1.163
1 Yr BETA 0.8018 52-week High/Low 24.74 / 8.18 Profit Margin-11.1275
Operating Cash Flow Growth-105.7947 Altman Z-Score2.1059 Free Cash Flow to Firm -22.145 Million
Earnings Report2023-07-11
View SEC Filings from ANGO instead.

View recent insider trading info

Angiodynamics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding ANGO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ANGO

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-02-07 by TROWBRIDGE STEPHEN A
  • 4: filed on 2023-02-07 by ROSENZWEIG RICHARD C
  • 4: filed on 2023-02-01 by Helsel Dave
  • 4: filed on 2022-10-12 by TROWBRIDGE STEPHEN A
  • 4: filed on 2022-10-11 by CLEMMER JAMES C
  • 4: filed on 2022-08-01 by Helsel Dave
  • 4: filed on 2022-07-22 by CLEMMER JAMES C
  • 4: filed on 2022-07-22 by CAMPBELL CHAD THOMAS
  • 4: filed on 2022-07-22 by NIGHAN WARREN JR
  • 4: filed on 2022-07-22 by Helsel Dave

    • Events (8k)

  • 8-K: filed on 2023-04-17:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-30:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-06:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-27:
    Item 8.01: Other Events
  • 8-K: filed on 2023-01-12:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-05:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-30:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-23:
    Item 8.01: Other Events
  • 8-K: filed on 2022-11-04:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-06:
    Item 8.01: Other Events

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    TROWBRIDGE STEPHEN A EVP AND CFO

    • Officer
    		 89,026 2023-02-03 5

    ROSENZWEIG RICHARD C SVP AND GENERAL COUNSEL

    • Officer
    		 15,730 2023-02-01 2

    HELSEL DAVE SVP GLOBAL OPERATIONS AND R&D

    • Officer
    		 19,189 2023-01-31 4

    CLEMMER JAMES C PRESIDENT AND CEO

    • Officer
    • Director
    		 450,407 2022-10-10 3

    REED JAN STERN

    • Director
    		 49,777 2022-07-20 1

    DONNELLY HOWARD W

    • Director
    		 111,794 2022-07-20 1

    JOHNSON WESLEY

    • Director
    		 88,281 2022-07-20 2

    METENY DENNIS S

    • Director
    		 122,978 2022-07-20 2

    AUEN EILEEN O'SHEA

    • Director
    		 49,461 2022-07-20 1

    NIGHAN WARREN JR SVP QUALITY AND REGULATORY

    • Officer
    		 54,498 2022-07-20 2

    TARNOFF MICHAEL E

    • Director
    		 28,121 2022-07-20 1

    CAMPBELL CHAD THOMAS SVP/GM, VASCULAR ACCESS

    • Officer
    		 55,069 2022-07-20 2

    LICITRA KAREN A

    • Director
    		 35,178 2022-07-20 1

    CENTEA SCOTT SVP/GM, VIT

    • Officer
    		 65,086 2022-07-20 1

    PICCININI LAURA SVP INTERNATIONAL

    • Officer
    		 26,469 2022-07-20 1

    GOULD KEVIN J

    • Director
    		 77,504 2020-07-14 0

    BOUCHER BRENT J. SVP AND GM OF ONCOLOGY

    • Officer
    		 15,416 2020-02-12 0

    GREINER MICHAEL EVP AND CFO

    • Officer
    		 0 2019-10-16 0

    SIMPSON ROBERT ARTHUR SVP/GM, GLOBAL VASCULAR

    • Officer
    		 15,441 2019-07-26 0

    GOLD JEFFREY

    • Director
    		 83,640 2019-07-17 0

    LAPORTE STEVE

    • Director
    		 48,484 2018-07-18 0

    RICHARD STARK SVP, GM - ONCOLOGY

    • Officer
    		 20,754 2017-11-15 0

    BURGSTAHLER DAVID F

    • Director
    • 10% Owner
    		 No longer subject to file 2017-04-12 0

    AVISTA CAPITAL PARTNERS GP, LLC

    AVISTA CAPITAL PARTNERS, L.P.

    AVISTA CAPITAL PARTNERS (OFFSHORE), L.P.

    NAVILYST MEDICAL CO-INVEST, LLC

    • 10% Owner
    		 No longer subject to file 2017-04-12 0

    VENKATARAMAN SRIRAM

    • Director
    		 No longer subject to file 2016-08-05 0

    GREINER CHARLES R VP - GLOBAL FRANCHISE

    • Officer
    		 20,910 2016-05-06 0

    SOTO JOHN SVP AND CCO

    • Officer
    		 22,452 2015-09-10 0

    DEVIVO JOSEPH PRESIDENT AND CEO

    • Officer
    • Director
    		 198,451 2015-09-08 0

    FROST MARK T EVP AND CFO

    • Officer
    		 38,389 2015-08-06 0

    KAPUSTA MATTHEW C SVP, BUSINESS DEVELOPMENT

    • Officer
    		 30,062 2014-11-17 0

    BOURNE GEORGE W. IV CTO AND COO

    • Officer
    		 23,613 2014-08-06 0

    MCGILL STEPHEN SVP, GM - INTERNATIONAL

    • Officer
    		 20,715 2014-01-28 0

    BUCCI VINCENT

    • Director
    		 143,312 2013-10-23 0

    GERSUK D JOSEPH EVP - CFO

    • Officer
    		 47,275 2012-09-04 0

    PANZER ALAN SVP, GM - VASCULAR

    • Officer
    		 27,500 2012-08-17 0

    ETLINGER RICHARD SCOTT SVP - GLOBAL OPERATIONS

    • Officer
    		 11,957 2012-08-17 0

    ECHENBERG PAUL S

    • DIRECTOR EMERITUS
    		 154,412 2012-04-23 0

    ORSATTI CHARLES THOMAS

    • Director
    		 0 2011-08-03 0

    SOLANO SCOTT J. INTERIM CEO

    • Officer
    		 8,945 2011-08-03 0

    KELTJENS JAN PRESIDENT & CEO

    • Officer
    • Director
    		 109,276 2011-01-19 0

    APPLING WILLIAM M VICE-PRESIDENT - RESEARCH

    • Officer
    		 16,636 2010-09-07 0

    MAPES HAROLD VP - OPERATIONS

    • Officer
    		 14,934 2010-09-07 0

    MCCARTHY SHAWN P SVP - GENERAL MANAGER

    • Officer
    		 10,392 2010-08-17 0

    WALLACE LYNDA M. SVP - BUSINESS DEVELOPMENT

    • Officer
    		 0 2010-05-17 0

    ROSSELL ROBERT M VP - MARKETING

    • Officer
    		 8,945 2009-10-08 0

    HOBBS EAMONN P PRESIDENT & CEO

    • Officer
    • Director
    		 100,401 2009-02-13 0

    MCDONALD DAVID SVP - BUSINESS DEVELOPMENT

    • Officer
    		 0 2008-10-21 0

    MORRIS SEAN SVP - GENERAL MANAGER

    • Officer
    		 10,253 2008-10-21 0

    FLAHERTY ROBERT E

    • Director
    		 3,700 2008-08-06 0

    GERARDI JOSEPH G VICE PRESIDENT

    • Officer
    		 32,992 2007-08-17 0

    KUNST BRIAN VP - REGULATORY AFFAIRS

    • Officer
    		 30,240 2007-08-17 0

    RECINELLA DANIEL VP - PRODUCT DEVELOPMENT

    • Officer
    		 41,174 2007-08-17 0

    MITCHELL ROBERT D EXECUTIVE VP AND COO

    • Officer
    		 63,542 2007-08-17 0

    SHEA PAUL J VP - SALES

    • Officer
    		 5,112 2007-08-09 0

    STERN LINDA B

    • 10% Owner
    		 1,576,687 2006-12-20 0

    GRAHAM PETER J

    • Director
    		 129,109 2006-10-25 0

    MEYERS DAVID P

    • Director
    		 375,706 2006-05-19 0

    ESTATE OF HOWARD S. STERN

    • 10% Owner
    		 1,647,687 2006-01-13 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ANGIODYNAMICS INC ANGO 2023-05-31 22:15:04 UTC 4.5106 0.5494 3100000
    ANGIODYNAMICS INC ANGO 2023-05-31 21:45:04 UTC 4.5106 0.5494 3100000
    ANGIODYNAMICS INC ANGO 2023-05-31 21:15:03 UTC 4.5106 0.5494 3100000
    ANGIODYNAMICS INC ANGO 2023-05-31 20:45:04 UTC 4.5106 0.5494 3100000
    ANGIODYNAMICS INC ANGO 2023-05-31 20:15:06 UTC 4.5106 0.5494 3100000
    ANGIODYNAMICS INC ANGO 2023-05-31 19:45:04 UTC 4.5106 0.5494 3100000
    ANGIODYNAMICS INC ANGO 2023-05-31 19:15:21 UTC 4.4447 0.6153 3100000
    ANGIODYNAMICS INC ANGO 2023-05-31 18:45:03 UTC 4.4447 0.6153 3000000
    ANGIODYNAMICS INC ANGO 2023-05-31 18:15:04 UTC 4.4447 0.6153 3000000
    ANGIODYNAMICS INC ANGO 2023-05-31 17:45:03 UTC 4.4447 0.6153 3000000
    ANGIODYNAMICS INC ANGO 2023-05-31 17:15:05 UTC 4.4447 0.6153 3100000
    ANGIODYNAMICS INC ANGO 2023-05-31 16:45:04 UTC 4.4026 0.6674 3100000
    ANGIODYNAMICS INC ANGO 2023-05-31 16:15:04 UTC 4.4026 0.6674 3100000
    ANGIODYNAMICS INC ANGO 2023-05-31 15:45:03 UTC 4.4026 0.6674 3100000
    ANGIODYNAMICS INC ANGO 2023-05-31 15:15:04 UTC 4.4026 0.6674 3100000
    ANGIODYNAMICS INC ANGO 2023-05-31 14:45:04 UTC 4.4026 0.6674 3000000
    ANGIODYNAMICS INC ANGO 2023-05-31 14:15:03 UTC 4.4026 0.6674 3100000
    ANGIODYNAMICS INC ANGO 2023-05-31 13:45:04 UTC 4.4407 0.6293 3100000
    ANGIODYNAMICS INC ANGO 2023-05-31 13:15:04 UTC 4.4407 0.6293 3100000
    ANGIODYNAMICS INC ANGO 2023-05-31 12:45:04 UTC 4.4407 0.6293 3000000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments